DPYD inhibition prevented uracil degradation and ameliorated lipid accumulation in an in vitro model of fatty acid-induced steatosis in a dose dependent manner; the observed difference in lipid phenotypes corresponded with an enhanced rate of mitochondrial respiration and decreased expression of genes associated with de novo lipogenesis, lipolysis, lipid storage, and gluconeogenesis. Here, DPYD is linked to steatosis.